Radiotherapy orchestrates natural killer cell dependent antitumor immune responses through CXCL8

放射疗法通过 CXCL8 调控自然杀伤细胞依赖的抗肿瘤免疫反应。

阅读:2
作者:Thomas Walle ,Joscha A Kraske,Boyu Liao,Bénédicte Lenoir,Carmen Timke,Emilia von Bohlen Und Halbach ,Florian Tran,Paul Griebel,Dorothee Albrecht,Azaz Ahmed ,Meggy Suarez-Carmona,Alejandro Jiménez-Sánchez,Tizian Beikert,Alexandra Tietz-Dahlfuß,Ayse Nur Menevse,Gabriele Schmidt,Manuela Brom,Jens H W Pahl,Wiebke Antonopoulos,Matthias Miller,Ramon Lopez Perez,Felix Bestvater,Nathalia A Giese,Philipp Beckhove,Philip Rosenstiel,Dirk Jäger ,Oliver Strobel,Dana Pe'er,Niels Halama   ,Jürgen Debus ,Adelheid Cerwenka,Peter E Huber

Abstract

Radiotherapy is a mainstay cancer therapy whose antitumor effects partially depend on T cell responses. However, the role of Natural Killer (NK) cells in radiotherapy remains unclear. Here, using a reverse translational approach, we show a central role of NK cells in the radiation-induced immune response involving a CXCL8/IL-8-dependent mechanism. In a randomized controlled pancreatic cancer trial, CXCL8 increased under radiotherapy, and NK cell positively correlated with prolonged overall survival. Accordingly, NK cells preferentially infiltrated irradiated pancreatic tumors and exhibited CD56dim-like cytotoxic transcriptomic states. In experimental models, NF-κB and mTOR orchestrated radiation-induced CXCL8 secretion from tumor cells with senescence features causing directional migration of CD56dim NK cells, thus linking senescence-associated CXCL8 release to innate immune surveillance of human tumors. Moreover, combined high-dose radiotherapy and adoptive NK cell transfer improved tumor control over monotherapies in xenografted mice, suggesting NK cells combined with radiotherapy as a rational cancer treatment strategy.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。